Continued discovery and expert testimony will be central to refining liability theories and exposures
Sinclair R, Tosti A, Schwartz JR, et al
Asia Pacific is expected to experience the fastest growth throughout the forecast period due to the rising prevalence of obesity and diabetes driven by rapid urbanization, changing lifestyles, and increasing awareness of metabolic health
That includes looking at all the angles of GLP-1 drugs, including their potential side effects and how effective they are when used for treatment or prevention of diabetes, obesity and other conditions. Challenges for employers and employees 91% increase in PMPM costs between 12 months prior to starting a GLP-1 compared to 12 months after 9 The average cost of GLP-1 drugs can exceed $1,000 per patient per month
Patients should undergo a comprehensive evaluation to identify the etiology of WR, after which a targeted and personalized intervention should be performed for each patient
Median HbA1c decreased by 8.7 mmol/mol with metformin and 14.2 mmol/mol with GLP-1RA therapy